Literature DB >> 19961819

Vertebroplasty for osteoporotic fracture? Think twice.

Scott Kinkade1, James J Stevermer.   

Abstract

Think twice before recommending vertebroplasty (VP) for symptomatic osteoporotic compression fractures. New studies suggest that it has little benefit; thus, VP should be considered only after other, more conservative options fail.

Entities:  

Mesh：

Year:  2009        PMID： 19961819      PMCID： PMC3183921     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  9 in total

1.  Thoracic and lumbar vertebroplasties performed in US Medicare enrollees, 2001-2005.

Authors:  Darryl T Gray; William Hollingworth; Nneka Onwudiwe; Richard A Deyo; Jeffrey G Jarvik
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

2.  Balancing science and informed choice in decisions about vertebroplasty.

Authors:  James N Weinstein
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

Review 3.  Vertebroplasty and kyphoplasty: a systematic review of 69 clinical studies.

Authors:  Paul A Hulme; Jörg Krebs; Stephen J Ferguson; Ulrich Berlemann
Journal:  Spine (Phila Pa 1976)       Date:  2006-08-01       Impact factor: 3.468

4.  Percutaneous vertebroplasty compared with optimal pain medication treatment: short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures. The VERTOS study.

Authors:  M H J Voormolen; W P T M Mali; P N M Lohle; H Fransen; L E H Lampmann; Y van der Graaf; J R Juttmann; X Jansssens; H J J Verhaar
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

5.  Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications.

Authors:  Michael J Lee; Mark Dumonski; Patrick Cahill; Tom Stanley; Daniel Park; Kern Singh
Journal:  Spine (Phila Pa 1976)       Date:  2009-05-15       Impact factor: 3.468

6.  A randomized trial of vertebroplasty for osteoporotic spinal fractures.

Authors:  David F Kallmes; Bryan A Comstock; Patrick J Heagerty; Judith A Turner; David J Wilson; Terry H Diamond; Richard Edwards; Leigh A Gray; Lydia Stout; Sara Owen; William Hollingworth; Basavaraj Ghdoke; Deborah J Annesley-Williams; Stuart H Ralston; Jeffrey G Jarvik
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

7.  A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.

Authors:  Rachelle Buchbinder; Richard H Osborne; Peter R Ebeling; John D Wark; Peter Mitchell; Chris Wriedt; Stephen Graves; Margaret P Staples; Bridie Murphy
Journal:  N Engl J Med       Date:  2009-08-06       Impact factor: 91.245

8.  Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures: three-months follow-up in a clinical randomized study.

Authors:  Rikke Rousing; Mikkel O Andersen; Stig M Jespersen; Karsten Thomsen; Jens Lauritsen
Journal:  Spine (Phila Pa 1976)       Date:  2009-06-01       Impact factor: 3.468

Review 9.  Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced-based review of the literature.

Authors:  Matthew J McGirt; Scott L Parker; Jean-Paul Wolinsky; Timothy F Witham; Ali Bydon; Ziya L Gokaslan
Journal:  Spine J       Date:  2009-02-28       Impact factor: 4.166
  9 in total
  3 in total

1.  Have referral patterns for vertebroplasty changed since publication of the placebo-controlled trials?

Authors:  M T Luetmer; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 2.  Invited editorial presents an accurate summary of the results of two randomised placebo-controlled trials of vertebroplasty.

Authors:  Rachelle Buchbinder; Richard H Osborne; David Kallmes
Journal:  Med J Aust       Date:  2010-03-15       Impact factor: 7.738

3.  Treatment of multiple osteoporotic vertebral compression fractures by percutaneous cement augmentation.

Authors:  Agnieszka Saracen; Zbigniew Kotwica
Journal:  Int Orthop       Date:  2014-08-09       Impact factor: 3.075
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.